Abstract
Introduction: Colorectal cancer is one of the most common malignancies in the world, and it exhibits differences in incidence, pathogenesis, molecular pathways, and outcome depending on the location of the tumor. Differences in the microbiome, clinical characteristics, and chromosomal and molecular characteristics have been reported between the right and left side of the colon. Areas covered: This review focuses on the latest developments in epidemiological and chromosomal and molecular studies, which have enhanced our understanding on the underlying genetic and immunological differences between the right-sided colon and the left-sided colorectum in metastatic colorectal cancer. Expert commentary: The numerous findings regarding differences between right- and left-sided colon cancers should have an impact on colorectal cancer screening and therapy. The location of the colorectal cancer should be considered before group stratification into genetic, clinical, and especially chemotherapy trials. A more tailored approach to colon cancer treatment would be highly desirable if future trials further support the hypothesis of two distinct tumor entities.
| Original language | English |
|---|---|
| Pages (from-to) | 351-358 |
| Number of pages | 8 |
| Journal | Expert Review of Anticancer Therapy |
| Volume | 18 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2018 Apr 3 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Oncology
- Pharmacology (medical)
Cite this
}
Difference between right-sided and left-sided colorectal cancers : from embryology to molecular subtype. / Yang, Seung Yoon; Cho, Min Soo; Kim, Nam Kyu.
In: Expert Review of Anticancer Therapy, Vol. 18, No. 4, 03.04.2018, p. 351-358.Research output: Contribution to journal › Review article
TY - JOUR
T1 - Difference between right-sided and left-sided colorectal cancers
T2 - from embryology to molecular subtype
AU - Yang, Seung Yoon
AU - Cho, Min Soo
AU - Kim, Nam Kyu
PY - 2018/4/3
Y1 - 2018/4/3
N2 - Introduction: Colorectal cancer is one of the most common malignancies in the world, and it exhibits differences in incidence, pathogenesis, molecular pathways, and outcome depending on the location of the tumor. Differences in the microbiome, clinical characteristics, and chromosomal and molecular characteristics have been reported between the right and left side of the colon. Areas covered: This review focuses on the latest developments in epidemiological and chromosomal and molecular studies, which have enhanced our understanding on the underlying genetic and immunological differences between the right-sided colon and the left-sided colorectum in metastatic colorectal cancer. Expert commentary: The numerous findings regarding differences between right- and left-sided colon cancers should have an impact on colorectal cancer screening and therapy. The location of the colorectal cancer should be considered before group stratification into genetic, clinical, and especially chemotherapy trials. A more tailored approach to colon cancer treatment would be highly desirable if future trials further support the hypothesis of two distinct tumor entities.
AB - Introduction: Colorectal cancer is one of the most common malignancies in the world, and it exhibits differences in incidence, pathogenesis, molecular pathways, and outcome depending on the location of the tumor. Differences in the microbiome, clinical characteristics, and chromosomal and molecular characteristics have been reported between the right and left side of the colon. Areas covered: This review focuses on the latest developments in epidemiological and chromosomal and molecular studies, which have enhanced our understanding on the underlying genetic and immunological differences between the right-sided colon and the left-sided colorectum in metastatic colorectal cancer. Expert commentary: The numerous findings regarding differences between right- and left-sided colon cancers should have an impact on colorectal cancer screening and therapy. The location of the colorectal cancer should be considered before group stratification into genetic, clinical, and especially chemotherapy trials. A more tailored approach to colon cancer treatment would be highly desirable if future trials further support the hypothesis of two distinct tumor entities.
UR - http://www.scopus.com/inward/record.url?scp=85044052572&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044052572&partnerID=8YFLogxK
U2 - 10.1080/14737140.2018.1442217
DO - 10.1080/14737140.2018.1442217
M3 - Review article
C2 - 29458272
AN - SCOPUS:85044052572
VL - 18
SP - 351
EP - 358
JO - Expert Review of Anticancer Therapy
JF - Expert Review of Anticancer Therapy
SN - 1473-7140
IS - 4
ER -